Investment25 Jul 2025, 03:25 pm
Laurus Labs to Invest INR Equivalent of Euro 5 Million in Joint Venture KRKA Pharma
AI Summary
The Board of Directors of Laurus Labs Ltd. has approved an investment of up to Euro 5 Million in KRKA Pharma Private Limited, a joint venture of the company. The investment will be used to meet the expenditure related to the civil works for setting up a manufacturing facility for production of finished products for new markets, including the Indian market. This investment aligns with the company’s strategic growth plans and long-term business objectives.
Key Highlights
- Laurus Labs to invest INR equivalent of Euro 5 Million in KRKA Pharma, a joint venture
- Investment to be used for setting up a manufacturing facility for production of finished products
- Investment aligns with the company’s strategic growth plans and long-term business objectives
- KRKA d.d., Novo mesto, Slovenia to also invest Euro 5 Million in KRKA
- Existing shareholding ratio of 51:49 between KRKA d.d., Novo mesto and Laurus Labs Limited to remain the same post-investment